Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1383941 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Interleukin 2 (IL2) antibody (FITC)
- Antibody type
- Monoclonal
- Antigen
- Other
- Description
- Ion exchange chromatography
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Green dye
- Isotype
- IgG
- Antibody clone number
- B-G5
- Vial size
- 1ml
- Storage
- Declared stable after 7 days at room temperature. Protect from light. Do not freeze.
- Handling
- It is recommended to establish the optimal dilution according to the system being used. Use 10 μL of (diluted) antibody to label 5 x 10 5 cells. Do not freeze.
Submitted references Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance.
Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma): inhibition by immunoglobulin a complexes.
Primary defect in CD8+ lymphocytes in the antibody deficiency disease (common variable immunodeficiency): abnormalities in intracellular production of interferon-gamma (IFN-gamma) in CD28+ ('cytotoxic') and CD28- ('suppressor') CD8+ subsets.
Vargas-Rojas MI, CrispĂn JC, Richaud-Patin Y, Alcocer-Varela J
Lupus 2008 Apr;17(4):289-94
Lupus 2008 Apr;17(4):289-94
Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma): inhibition by immunoglobulin a complexes.
Woerly G, Roger N, Loiseau S, Dombrowicz D, Capron A, Capron M
The Journal of experimental medicine 1999 Aug 16;190(4):487-95
The Journal of experimental medicine 1999 Aug 16;190(4):487-95
Primary defect in CD8+ lymphocytes in the antibody deficiency disease (common variable immunodeficiency): abnormalities in intracellular production of interferon-gamma (IFN-gamma) in CD28+ ('cytotoxic') and CD28- ('suppressor') CD8+ subsets.
North ME, Webster AD, Farrant J
Clinical and experimental immunology 1998 Jan;111(1):70-5
Clinical and experimental immunology 1998 Jan;111(1):70-5
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- A typical staining pattern with the B-G5 monoclonal antibody of PMA and ionomycin activated PBL